Monica Carpenedo - Concepedia

Author

Monica Carpenedo

Azienda Ospedaliera San Gerardo ORCID

Also Known As

M Carpenedo, M. CARPENEDO, M. Carpenedo, Monica Carpenedo

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliera San Gerardo Ospedale San Bortolo Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Istituti di Ricovero e Cura a Carattere Scientifico University of Milan

About

Monica Carpenedo is an author at Azienda Ospedaliera San Gerardo specializing in medicine, thrombosis, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	555
2	Health Sciences	3	4	196
3	Public Health	2	2	98
4	Emergency Medicine	2	2	51
5	Epidemiology	1	1	41

Monica Carpenedo

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients Wilma Barcellini, Bruno Fattizzo, Anna Zaninoni, Blood	2014	359
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia Bianca Rocca, Alberto Tosetto, Silvia Betti, Blood	2020	100
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long‐term response Miriam Marangon, Nicola Vianelli, Francesca Palandri, European Journal Of Haematology	2016	89
Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different intensity targets Raffaele Sacco, Michele Sacco, Monica Carpenedo, Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology ThrombosisVenous ThrombosisOral SurgeryOutcomes ResearchSurgery	2007	89
Health‐related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease Fabio Efficace, Franco Mandelli, Paola Fazi, American Journal of Hematology	2016	80
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa, The Lancet ThrombopoiesisAutoimmune DiseaseBlood PlateletPrimary Immune ThrombocytopeniaImmunology	2023	77
D-dimer before chemotherapy might predict venous thromboembolism Guido Arpaia, Monica Carpenedo, Magda Verga, Blood Coagulation & Fibrinolysis	2009	71
Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)1 Sergio Siragusa, U Armani, Monica Carpenedo, Thrombosis Research ThrombosisPulmonary EmbolismVenous ThrombosisOncologyCardiovascular Disease	2011	57
Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia Francesca Palandri, Elena Rossi, Daniela Bartoletti, Blood	2021	53
Accuracy of a Portable Prothrombin Time Monitor (Coagucheck) in Patients on Chronic Oral Anticoagulant Therapy Benilde Cosmi, Gualtiero Palareti, Marco Moia, Thrombosis Research ThrombosisVenous ThrombosisCardiovascular DiseaseStrokeHematology	2000	51

Page 1